Well Told Grants

Grants / Department of Health and Human Services / National Institutes of Health

PA-21-232: Comprehensive Care for Adults with Type 2 Diabetes Mellitus from Populations with Health Disparities (R01 Clinical Trial Optional)

Closed Closed September 7, 2024 Opportunity PA-21-232

This grant is closed. Who won this program's grants before is below, and similar open grants are at the end of the page. It is in our archive of National Institutes of Health notices from 2021.

National Institutes of Health offered grants of up to $500,000 to nonprofits, colleges and universities, state and local governments, tribes, small businesses and businesses. Applications closed on September 7, 2024.

From the official notice on Grants.gov, last changed May 26, 2021. Checked November 7, 2026.

About this NIH notice

Projects funded under PA-21-232 were run by National Institute on Minority Health and Health Disparities (NIMHD, 1 project) and National Institute of Diabetes and Digestive and Kidney Diseases (NIDDK, 1 project). Contact the program officer at the institute that fits your project before you apply; the notice lists them.

Application due dates, page limits and budget limits are set in the notice. Read PA-21-232 in the NIH Guide.

Key dates

PostedMay 26, 2021
DeadlineSeptember 7, 2024
Archived by Grants.govOctober 13, 2024

Who can apply

This opportunity was open to nonprofits, colleges and universities, state and local governments, tribes, small businesses and businesses.

All 15 applicant types the notice lists

Other Eligible Applicants include the following: Alaska Native and Native Hawaiian Serving Institutions; Asian American Native American Pacific Islander Serving Institutions (AANAPISISs); Faith-based or Community-based Organizations; Hispanic-serving Institutions; Historically Black Colleges and Universities (HBCUs); Indian/Native American Tribal Governments (Other than Federally Recognized); Regional Organizations; Tribally Controlled Colleges and Universities (TCCUs) ; U.S. Territory or Possession; Non-domestic (non-U.S.) Entities (Foreign Institutions) are not eligible to apply. Non-domestic (non-U.S.) components of U.S. Organizations are not eligible to apply. Foreign components, as defined in the NIH Grants Policy Statement, are not allowed.

More grants for nonprofits, colleges and universities, state and local governments, tribes, small businesses, businesses.

Is this a realistic fit?

What the grant funds

The purpose of this Funding Opportunity Announcement (FOA) is to support innovative multidisciplinary and multi-level research designed to develop and/or test interventions to optimize care of persons with Type 2 diabetes from populations with health/health care disparities concordant with evidence-based guidelines. NIH-designated health disparity populations include racial and ethnic minorities (Blacks/African Americans, Hispanics/Latinos, American Indians/Alaska Natives, Asians, Native Hawaiians and other Pacific Islanders), sexual and gender minorities, socioeconomically disadvantaged populations, and underserved rural populations. Proposed projects would be expected to develop and/or test patient-centered strategies, which in addition to optimal glycemic control, would aim at completing other recommended guidelines (e.g., annual eye/foot and urine albumin exam, optimal blood pressure control, intake of ACEIs or ARBs/statin/aspirin and influenza/pneumonia vaccines).

Category: Food and Nutrition, Health.

Funded under PA-21-232 so far

NIH funded 2 projects under PA-21-232 in fiscal 2023 to 2026, at 2 institutions. The median yearly award was $680,181.

Recently funded projects
ProjectInstitutionFiscal yearAward
Implementing Scalable, PAtient-centered Team-based Care for Adults with Type 2 Diabetes and Health Disparities (iPATH) R01Stanford University2026$679,371
ARISE (Achieving Routine Intervention and Screening for Emotional health) R01University of Chicago2026$680,991

From NIH RePORTER, which lists each project once per fiscal year it was funded. Amounts are the yearly award.

Who has won Diabetes, Digestive, and Kidney Diseases Extramural Research grants before

From fiscal 2021 to 2025, Diabetes, Digestive, and Kidney Diseases Extramural Research (93.847) awarded $9.6 billion across 7,877 grant awards, an average of $1.2 million per award.

Largest recipients, fiscal 2021 to 2025
RecipientStateAwardsAmount
Regents of the University of MichiganMichigan273$345 million
The Trustees of the University of PennsylvaniaPennsylvania187$272 million
University of Pittsburgh - of the Commonwealth System of Higher EducationPennsylvania209$238 million
The Washington UniversityMissouri187$227 million
The Regents of the University of California, San FranciscoCalifornia176$208 million

Top states: California ($1.2 billion), Massachusetts ($932 million), New York ($798 million), Pennsylvania ($762 million), Texas ($482 million).

Who has won Vision Research grants before

From fiscal 2021 to 2025, Vision Research (93.867) awarded $3.4 billion across 3,275 grant awards, an average of $1.0 million per award.

Largest recipients, fiscal 2021 to 2025
RecipientStateAwardsAmount
The Johns Hopkins UniversityMaryland137$139 million
The Leland Stanford Junior UniversityCalifornia87$96.5 million
The Regents of the University of California, San FranciscoCalifornia78$89.9 million
Duke UniversityNorth Carolina79$75.5 million
The Trustees of the University of PennsylvaniaPennsylvania57$73.9 million

Top states: California ($598 million), New York ($327 million), Massachusetts ($313 million), Texas ($221 million), Pennsylvania ($188 million).

Who has won Minority Health and Health Disparities Research grants before

From fiscal 2021 to 2025, Minority Health and Health Disparities Research (93.307) awarded $2.0 billion across 1,237 grant awards, an average of $1.6 million per award.

Largest recipients, fiscal 2021 to 2025
RecipientStateAwardsAmount
The Johns Hopkins UniversityMaryland37$69.3 million
The Trustees of Columbia University in the City of New YorkNew York25$59.1 million
University of HawaiiHawaii18$52.8 million
The Regents of the University of California, San FranciscoCalifornia24$49.5 million
The Morehouse School of Medicine, Inc.Georgia4$44.1 million

Top states: California ($301 million), New York ($187 million), Texas ($126 million), Maryland ($106 million), Massachusetts ($97.2 million).

Applying now

This notice no longer takes applications. Agencies often post the same opportunity again under a new number, so check the program's notices on Grants.gov and the similar open grants below.

The notice on Grants.gov keeps its full text and attachments, which is useful for planning a resubmission.

Questions people ask

Is PA-21-232 still open?

No. It closed on September 7, 2024.

Who can apply for Comprehensive Care for Adults with Type 2 Diabetes Mellitus from Populations with Health Disparities (R01 Clinical Trial Optional)?

National Institutes of Health accepted applications from nonprofits, colleges and universities, state and local governments, tribes, small businesses and businesses. The notice adds further conditions, so read its eligibility section.

What is the deadline for Comprehensive Care for Adults with Type 2 Diabetes Mellitus from Populations with Health Disparities (R01 Clinical Trial Optional)?

Closed September 7, 2024. Applications are no longer accepted; the program's newer notices are on this page when there are any.

How much funding is available?

Awards of up to $500,000 each.

Who has been funded under PA-21-232?

NIH RePORTER lists 2 projects funded under PA-21-232 in fiscal 2023 to 2026, at 2 institutions. The most were at Stanford University, University of Chicago.

Who has won Minority Health and Health Disparities Research grants before?

The largest recipients over five fiscal years were The Johns Hopkins University, The Trustees of Columbia University in the City of New York, University of Hawaii. The program made 1,237 awards worth $2.0 billion in that time.

Similar open grants